Allergan’s Botox trade secrets win at the ITC underlines its growing importance in life sciences IP disputes

Victory for the US company and its Korean partner Medytox shows how Section 337 proceedings are becoming a vital enforcement tool for pharma and biotech rights owners

Unlock unlimited access to all IAM content